Industry Standards in Opiate Addiction Recovery
Rapid opiate detox was created in Israel almost 20 years ago by Dr. Andre Waismann, who still practices his craft in Barzilai Medical Center in Ashkelon, Israel.
The original procedure was used on addicted soldiers in Israeli army. It utilized many slow acting oral medications and usually required extended periods under anesthesia – currently recognized as high risk. While some advances have been made the detox is done under general anesthesia to avoid extreme discomfort and pain from opioid withdrawal symptoms.
During the period of follow-up an average of 50% were abstinent from opiates.
Read more about the old way of rapid detox
Rapid detox under anesthesia can get you through the worst of withdrawal with only limited amount of symptoms that one can help to manage. There is scientific disagreement as to the safety of this procedure. Rapid detoxification has been criticized by some for its questionable efficacy in long-term opioid dependence management. Rapid detoxification has often been misrepresented as a one-off “cure” for opioid dependence, when it is only intended as the initial step in an overall drug rehabilitation regimen. Rapid detoxification can be effective for short-term opioid detoxification, but is approximately 10 times more expensive than conventional detoxification procedures. Aftercare can also be an issue.
Ultra Rapid Detox
Ultra-Rapid Detoxification (URD) is a technique that was pioneered to help people detoxify from opiates. Because older detoxification techniques were painful and usually unsuccessful, URD was developed. URD involves putting patients under general anesthesia and giving them Naltrexone to flush all of the opiates off the brain receptors. It is always successful but it is a major shock to the patient’s system. Patients usually feel absolutely terrible after the procedure and there are some risks involved. Approximately 1/500 to 1/1,000 patients die after the procedure and the exact cause of death is unknown. During the period of follow-up an average of 60% were abstinent from opiates.
Read about more recent Ultra Rapid Detox
There are a number of centers around the world who still perform URD and in a supervised setting with experienced personnel and it seems to be a reasonable procedure where the risks are sometimes outweighed by the benefits.
Intensive Outpatient Opiate Treatment (IOOT™)
Intensive Outpatient Opiate Treatment (IOOT™) Medical advances and hybrid technology condenses the procedure into a few hours. The process speeds your body’s detoxification process and overcomes withdrawal symptoms in minutes. IOOT™ is a homogenous process that with just minor sedation and unlike rapid detox Medically Assisted Therapy (MAT) achieves patient comfort without general anesthesia, intubation or external ventilation. Intensive Opiate Treatment is part of overall drug rehabilitation regimen performed in a (ASAM) American Society of Addiction Level III.2-D & III.7-D facility that includes National Institute on Drug Abuse (NIDA) recommendations of detoxification coupled with both medication, behavioral therapy, followed by relapse prevention. During the period of follow-up an average of 90% were abstinent from opiates.
Read about the most effective, patented Clarity IOOT process
Detox with Clarity IOOT™ is done in hours. Most patients say they are completely comfortable during the process. You will not be struggling through painful weeks of withdrawal. You will not need to be absence from work, school or family. Naltrexone is a core component to Intensive Outpatient Opiate Treatment IOOT™ which is a medically based treatment program conducted by a multidisciplinary team of doctors, nurses and therapists trained in addiction medicine. Naltrexone saturation (IV, IM [depot], Implant, and Oral) is accomplished in hours without a lengthy period of opiate abstinence (which could be several very difficult weeks) or use of staged ramp down with alternative opiates. Naltrexone is recognized as a Medically Accepted Treatment (MAT) and is considered advantageous as it is a full opiate antagonist and contains no opiates like suboxone or methadone. Nora Volkow, M.D., Director of the National Institute on Drug Abuse (NIDA), stated … “As a depot formulation, dosed monthly, Naltrexone eliminates the daily need for patients to motivate themselves to stick to a treatment regimen – a formidable task, especially in the face of multiple triggers of craving and relapse.
10 key IOOT™ components needed for long term success in managing and treating this chronic disease.
Disease explanation, risk, behavior, treatment possibilities.
Complete Biological, Social, Psychological analysis.
Medical, Psychological guidance for patient and family.
Pre-operative preparation of patient
Mitigation of withdrawal symptoms, accelerated blocking of opiate receptors.
Medical management of post-operative symptoms.
Rest and restorative period, aftercare support.
Medical and psychological clearance, delivery of multi-disciplinary aftercare directive, appropriate referrals performed, scheduling of 12 month tele health/video health sessions with addition specialists.
Abstinent enhancement through “Sentinel” oversight, traditional 12 step, group and individual outreach programs.
Extended use (1 year) of opiate antagonists (blocker) with monthly IM support.